WOLVERINE ASSET MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$344,000
-29.1%
14,500
-46.3%
0.00%
-57.1%
Q1 2020$485,000
+54.0%
27,000
+103.0%
0.01%
+75.0%
Q4 2019$315,000
+584.8%
13,300
+680.1%
0.00%
+300.0%
Q3 2019$46,000
-17.9%
1,7050.0%0.00%0.0%
Q2 2019$56,000
-5.1%
1,7050.0%0.00%0.0%
Q1 2019$59,000
+5.4%
1,7050.0%0.00%0.0%
Q4 2018$56,000
-34.1%
1,7050.0%0.00%0.0%
Q3 2018$85,000
+8400.0%
1,705
+2335.7%
0.00%
Q4 2015$1,0000.0%700.0%0.00%
Q3 2015$1,0000.0%700.0%0.00%
Q2 2015$1,000
-92.3%
70
-93.5%
0.00%
Q1 2015$13,000
-96.6%
1,070
-97.6%
0.00%
-100.0%
Q4 2014$385,000
+39.0%
45,265
+43.8%
0.01%
+16.7%
Q3 2014$277,000
-22.8%
31,4670.0%0.01%
-25.0%
Q2 2014$359,000
-35.0%
31,467
-28.7%
0.01%
-27.3%
Q1 2014$552,000
+145.3%
44,108
+75.8%
0.01%
+120.0%
Q4 2013$225,000
-51.6%
25,087
-57.5%
0.01%
-50.0%
Q3 2013$465,000
-48.2%
59,052
-55.9%
0.01%
-56.5%
Q2 2013$897,000133,8040.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders